Maternal B12 Supplementation to Improve Infant B12 Deficiency and Neurodevelopment (MATCOBIND)
A Randomised Controlled Trial to Compare Two Different Doses of Maternal B12 Supplementation in Improving Infant B12 Deficiency and Neurodevelopment
Sponsor: Paropakar Maternity and Women's Hospital
Listed as NCT03783104, this NA trial focuses on Child Developmental Delay and Child Malnutrition and remains ongoing. Sponsored by Paropakar Maternity and Women's Hospital, it has been updated 6 times since 2019, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2022 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Jan 2022 [monthly]
Recruiting NA
-
Aug 2019 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Jan 2019 — Aug 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Paropakar Maternity and Women's Hospital
- Sitaram Bhartia Institute of Science and Research
- University College, London
For direct contact, visit the study record on ClinicalTrials.gov .